EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

Scope Biosciences B.V.

Start-ups and SMEs

www.scopebio.comWageningen, Netherlands

About

Scope Biosciences B.V. is a Dutch biotech company pioneering next-generation molecular diagnostics through its patented scopeDx® platform, based on a unique type III CRISPR-Cas system. A spin-off from Wageningen University, Scope Biosciences aims to democratize diagnostics by combining the speed and ease-of-use of immunoassays with the accuracy of PCR, delivering results within 30 minutes at the point-of-care. Under the EU-funded EIC Transition project (2024–2026), the company is advancing scopeDx® from proof-of-concept to a complete sample-to-answer solution for clinical applications, emphasizing modularity, specificity (SNP-level), and on-site usability

Objectives

Building consortiaLooking for investmentsSeeking advice and experiences

Topics

Agriculture & FoodClimate & Environmental TechMedical Technologies

Representatives

Niek Savelkoul

CEO

Scope Biosciences B.V.

Marketplace (2)